Dose-response of acute urinary toxicity of long-course preoperative chemoradiotherapy for rectal cancer

References

• Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 2010;76:S116–22.
   PubMed Web of Science ®Google Scholar
• Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1257–80.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124–9.
   PubMed Web of Science ®Google Scholar
• Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995;32:1289–300.
   PubMed Web of Science ®Google Scholar
• Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 2012;23:2479–516.
   PubMed Web of Science ®Google Scholar
• Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010;76:1005–11.
   PubMed Web of Science ®Google Scholar
• Arbea L, Ramos LI, Martínez-Monge R, Moreno M, Aristu J. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): Dosimetric comparison and clinical implications. Radiat Oncol 2010;5:17.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Muren LP. Advancing our quantitative understanding of radiotherapy normal tissue morbidity. Acta Oncol 2014;53:577–9.
   PubMed Web of Science ®Google Scholar
• Hansen JW, Jakobsen A. The importance of applicator design for intraluminal brachytherapy of rectal cancer. Med Phys 2006;33:3220–4.
   PubMed Web of Science ®Google Scholar
• Jakobsen A, Ploen J, Vuong T, Appelt A, Lindebjerg J, Rafaelsen SR. Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: A randomized trial comparing two radiation doses. Int J Radiat Oncol Biol Phys 2012;84 :949–54.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Blanco AI, Clark VH. CERR: A computational environment for radiotherapy research. Med Phys 2003; 30:979–85.
   PubMed Web of Science ®Google Scholar
• Niemierko A. A generalized concept of equivalent uniform dose (EUD). Med Phys 1999;26:1100.
   Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974;19:716–23.
   Web of Science ®Google Scholar
• Fagerland MW, Hosmer DW. A goodness-of-fit test for the proportional odds regression model. Stat Med 2013;32: 2235–49.
   PubMed Web of Science ®Google Scholar
• Rosewall T, Catton C, Currie G, Bayley A, Chung P, Wheat J, et al. The relationship between external beam radiotherapy dose and chronic urinary dysfunction – a methodological critique. Radiother Oncol 2010;97:40–7.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Valdagni R, Rancati T, Sanguineti G. Dose- volume effects for normal tissues in external radiotherapy: Pelvis. Radiother Oncol 2009;93:153–67.
   PubMed Web of Science ®Google Scholar
• Karlsdóttir A, Johannessen DC, Muren LP, Wentzel-Larsen T, Dahl O. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 2004;71:43–53.
   PubMed Web of Science ®Google Scholar
• Harsolia A, Vargas C, Yan D, Brabbins D, Lockman D, Liang J, et al. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study. Int J Radiat Oncol Biol Phys 2007;69:1100–9.
   PubMed Web of Science ®Google Scholar
• Appelt AL, Vogelius IR, Farr KP, Khalil AA, Bentzen SM. Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors. Acta Oncol 2014;53:605–12.
   PubMed Web of Science ®Google Scholar
• Samuelian JM, Callister MD, Ashman JB, Young-Fadok TM, Borad MJ, Gunderson LL. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2012;82:1981–7.
   PubMed Web of Science ®Google Scholar
• Appelt AL, Pløen J, Vogelius IR, Bentzen SM, Jakobsen A. Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 2013;85:74–80.
   PubMed Web of Science ®Google Scholar
• Passoni P, Fiorino C, Slim N, Ronzoni M, Ricci V, Di Palo S, et al. Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: Boosting the dose to the shrinking tumor. Int J Radiat Oncol Biol Phys 2013;87:67–72.
   PubMed Web of Science ®Google Scholar
• Beetz I, Schilstra C, van Luijk P, Christianen MEMC, Doornaert P, Bijl HP, et al. External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol 2012;105:94–100.
   PubMed Web of Science ®Google Scholar
• Tucker SL, Mohan R, Liengsawangwong R, Martel MK, Liao Z. Predicting pneumonitis risk: A dosimetric alternative to mean lung dose. Int J Radiat Oncol Biol Phys 2013;85:522–7.
   PubMed Web of Science ®Google Scholar
• Dörr W, Bentzen SM. Late functional response of mouse urinary bladder to fractionated X-irradiation. Int J Radiat Biol 1999;75:1307–15.
   PubMed Web of Science ®Google Scholar
• Dörr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001;61:223–31.
   PubMed Web of Science ®Google Scholar
• Wallner C, Lange MM, Bonsing BA, Maas CP, Wallace CN, Dabhoiwala NF, et al. Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: A study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial. J Clin Oncol 2008;26:4466–72.
   PubMed Web of Science ®Google Scholar